About BioLife Solutions, Inc.
https://www.biolifesolutions.comBioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.
CEO
Roderick de Greef
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-01-29 | Reverse | 1:14 |
| 2000-06-16 | Reverse | 1:5 |
ETFs Holding This Stock
Summary
Showing Top 3 of 135
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
CASDIN CAPITAL, LLC
Shares:6.71M
Value:$162.92M
BLACKROCK, INC.
Shares:5.6M
Value:$136.04M
BLACKROCK INC.
Shares:5.49M
Value:$133.31M
Summary
Showing Top 3 of 221
About BioLife Solutions, Inc.
https://www.biolifesolutions.comBioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $28.07M ▲ | $18.16M ▼ | $621K ▲ | 2.21% ▲ | $0.01 ▲ | $2.55M ▲ |
| Q2-2025 | $25.42M ▲ | $33.08M ▲ | $-15.84M ▼ | -62.3% ▼ | $-0.33 ▼ | $-14.33M ▼ |
| Q1-2025 | $23.94M ▲ | $17M ▲ | $-448K ▼ | -1.87% ▲ | $-0.01 ▼ | $166K ▼ |
| Q4-2024 | $-3.42M ▼ | $-16.5M ▼ | $12.46M ▲ | -363.87% ▼ | $0.27 ▲ | $6.75M ▲ |
| Q3-2024 | $30.57M | $23.36M | $-1.7M | -5.57% | $-0.04 | $853K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $78.95M ▼ | $392.08M ▲ | $38.34M ▼ | $353.74M ▲ |
| Q2-2025 | $81.77M ▼ | $387.24M ▼ | $40.09M ▼ | $347.15M ▼ |
| Q1-2025 | $88.58M ▼ | $395.14M ▼ | $42.52M ▼ | $352.62M ▲ |
| Q4-2024 | $104.58M ▲ | $399.49M ▲ | $50.58M ▼ | $348.91M ▲ |
| Q3-2024 | $34.19M | $381.65M | $56.19M | $325.46M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $621K ▲ | $6.1M ▼ | $-5.97M ▲ | $5.87M ▲ | $0 ▲ | $2.8M ▼ |
| Q2-2025 | $-15.84M ▼ | $7.37M ▲ | $-39.53M ▼ | $-2.88M ▲ | $-35.04M ▼ | $5.63M ▲ |
| Q1-2025 | $-448K ▼ | $1.73M ▲ | $-27.18M ▼ | $-2.99M ▲ | $-28.44M ▼ | $1.55M ▲ |
| Q4-2024 | $12.46M ▲ | $1.65M ▼ | $73.64M ▲ | $-4.09M ▼ | $71.22M ▲ | $583K ▼ |
| Q3-2024 | $-15.28M | $4.8M | $-1.68M | $-1.04M | $2.12M | $3.69M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Product | $30.00M ▲ | $20.00M ▼ | $20.00M ▲ | $30.00M ▲ |
 Rental Revenue | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Service | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Roderick de Greef
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-01-29 | Reverse | 1:14 |
| 2000-06-16 | Reverse | 1:5 |
ETFs Holding This Stock
Summary
Showing Top 3 of 135
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
CASDIN CAPITAL, LLC
Shares:6.71M
Value:$162.92M
BLACKROCK, INC.
Shares:5.6M
Value:$136.04M
BLACKROCK INC.
Shares:5.49M
Value:$133.31M
Summary
Showing Top 3 of 221